Agency Forms Undergoing Paperwork Reduction Act Review, 62857-62858 [2022-22502]
Download as PDF
<![CDATA[
62857
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
CDC Award Recipients ...................................
Performance Progress and Monitoring Report (PPMR—Att. A–F).
Performance Progress and Monitoring Report (PPMR—Att. G).
Performance Progress and Monitoring Report (PPMR—Att. A–F).
CDC Award Recipients ...................................
NHSS Award Recipients .................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–22505 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22CC]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessment for
the Be Antibiotics Aware (BAA)
Consumer and Healthcare Professional
Campaign’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on January
31, 2022, to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Assessment for the Be Antibiotics
Aware (BAA) Consumer and Healthcare
Professional Campaign—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Antibiotic resistance (AR) is one of
the most urgent threats to public health
in the United States. Antibiotic resistant
bacteria have grown more virulent,
prevalent, and diverse and can spread
between human and animals. Each year
there are more than 2.8 million
antibiotic-resistant infections in the
United States and 35,000 individuals
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
5,200
1
2
1,632
1
5/60
60
1
40
die as a result. At least 30% of
antibiotics prescribed to outpatients and
emergency departments are unnecessary
which amounts to 47 million excess
prescriptions per year. One of the main
side effects of taking antibiotics is
alteration of the microbiome which
could lead to infections such as C.
difficile, the inability to treat infections,
prolonged illness, or even death. Risk
factors for AR include lack of
knowledge, sub-therapeutic doses,
excessive use, antibiotic residues, and
incorrect storage. In addition, there can
be impacts on productivity, healthcare
costs, and it can serve as a drain on the
economy.
The National Action Plan calls for
federal agencies to accelerate their
response to AR. The 2020–2025
National Action Plan calls for CDC to
decrease healthcare-associated AR
infections by 20% by 2025 and
community-acquired AR infections by
10% by 2025. One way to decrease the
use of unnecessary antibiotic
prescriptions is through antibiotic
stewardship. The goals of the Be
Antibiotics Aware campaign are to seek
optimization of antibiotic prescribing
and use in order to improve patient
safety and healthcare quality, and to
combat AR by raising knowledge and
awareness, and motivating behavior
change among consumer and healthcare
professional (HCP) audiences.
Online panel surveys will be utilized
to recruit participants. Surveys will be
distributed to consumer and HCP
audiences both pre- and post-campaign.
Consumer audiences include:
(1) Healthy adults who visit urgent
care, ages 18–64,
(2) Community dwelling older adults,
ages 65+, and
(3) Family caregivers of nursing home
(long-term care) residents.
HCP audiences include:
(1) Hospitalists,
(2) Dentists,
(3) Community pharmacists,
(4) Physicians and advanced practice
providers in nursing homes, and
(5) Nurses in nursing homes.
E:\FR\FM\17OCN1.SGM
17OCN1
62858
Federal Register / Vol. 87, No. 199 / Monday, October 17, 2022 / Notices
This program evaluation will assist
CDC in determining if the Be Antibiotics
Aware media campaign, along with
partner outreach, was successful in
raising knowledge and awareness and
motivating behavior change among the
CDC requests OMB approval for an
estimated 842 annual burden hours.
There is no cost to respondents other
than their time to participate.
intended consumer and HCP audiences
in select markets. The information
gathered from this evaluation will also
be used to inform refinement and
implementation of the campaign
(materials and tactics).
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Consumer Audiences ......................................
Consumer Audiences ......................................
HCP Audiences ...............................................
Consumer Audiences ......................................
BAA Consumer Pre-Campaign Web Survey
BAA Consumer Post-Campaign Web Survey
BAA HCP .......................................................
BAA Consumer Pre-Campaign Web Survey
Pre-Campaign Web Survey ...........................
BAA HCP Post-Campaign Web Survey ........
473
473
788
473
........................
788
1
1
1
1
........................
1
20/60
20/60
20/60
20/60
........................
20/60
HCP Audiences ...............................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–22502 Filed 10–14–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22EN]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Synopses of
State Dental Public Health Programs’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on May 6, 2022 to obtain
comments from the public and affected
agencies. CDC received one comment.
This notice serves to allow an additional
30 days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agency’s estimate of the burden of the
VerDate Sep<11>2014
17:35 Oct 14, 2022
Jkt 259001
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Synopses of State Dental Public
Health Programs—Existing Collection in
use without an OMB Control Number—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Background and Brief Description
This request is to collect information
about human resources, programs, and
infrastructure in oral health
departments within a state health
department for all 50 states and
Washington, DC. Oral health affects our
ability to eat, speak, smile, and show
emotions. Oral health also affects a
person’s self-esteem, school
performance, and attendance at work or
school. Oral diseases—which range
from cavities and gum disease to oral
cancer—cause pain and disability for
millions of Americans and cost
taxpayers billions of dollars each year.
CDC supports states in their efforts to
reduce oral disease and improve oral
health by using effective interventions.
CDC provides state and territorial health
departments with funding, guidance,
and technical assistance to monitor oral
disease across populations and to
implement and evaluate oral health
interventions.
The Association of State and
Territorial Dental Directors (ASTDD) is
a national non-profit organization
representing the directors and staff of
state public health agency programs for
oral health. It was organized in 1948
and is one of 20 affiliates of the
Association of State and Territorial
Health Officials (ASTHO). ASTDD
formulates and promotes the
establishment of national dental public
health policy. In addition, ASTDD;
assists state dental programs in the
development and implementation of
programs and policies for the
prevention of oral diseases; builds
awareness and strengthens dental public
health professionals’ knowledge and
skills by developing position papers and
policy statements; provides information
on oral health to health officials and
policy makers; and conducts
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Pages 62857-62858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22502]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22CC]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Assessment for the Be Antibiotics Aware
(BAA) Consumer and Healthcare Professional Campaign'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on January 31, 2022, to obtain comments from
the public and affected agencies. CDC received one comment related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Assessment for the Be Antibiotics Aware (BAA) Consumer and
Healthcare Professional Campaign--New--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Antibiotic resistance (AR) is one of the most urgent threats to
public health in the United States. Antibiotic resistant bacteria have
grown more virulent, prevalent, and diverse and can spread between
human and animals. Each year there are more than 2.8 million
antibiotic-resistant infections in the United States and 35,000
individuals die as a result. At least 30% of antibiotics prescribed to
outpatients and emergency departments are unnecessary which amounts to
47 million excess prescriptions per year. One of the main side effects
of taking antibiotics is alteration of the microbiome which could lead
to infections such as C. difficile, the inability to treat infections,
prolonged illness, or even death. Risk factors for AR include lack of
knowledge, sub-therapeutic doses, excessive use, antibiotic residues,
and incorrect storage. In addition, there can be impacts on
productivity, healthcare costs, and it can serve as a drain on the
economy.
The National Action Plan calls for federal agencies to accelerate
their response to AR. The 2020-2025 National Action Plan calls for CDC
to decrease healthcare-associated AR infections by 20% by 2025 and
community-acquired AR infections by 10% by 2025. One way to decrease
the use of unnecessary antibiotic prescriptions is through antibiotic
stewardship. The goals of the Be Antibiotics Aware campaign are to seek
optimization of antibiotic prescribing and use in order to improve
patient safety and healthcare quality, and to combat AR by raising
knowledge and awareness, and motivating behavior change among consumer
and healthcare professional (HCP) audiences.
Online panel surveys will be utilized to recruit participants.
Surveys will be distributed to consumer and HCP audiences both pre- and
post-campaign. Consumer audiences include:
(1) Healthy adults who visit urgent care, ages 18-64,
(2) Community dwelling older adults, ages 65+, and
(3) Family caregivers of nursing home (long-term care) residents.
HCP audiences include:
(1) Hospitalists,
(2) Dentists,
(3) Community pharmacists,
(4) Physicians and advanced practice providers in nursing homes,
and
(5) Nurses in nursing homes.
[[Page 62858]]
This program evaluation will assist CDC in determining if the Be
Antibiotics Aware media campaign, along with partner outreach, was
successful in raising knowledge and awareness and motivating behavior
change among the intended consumer and HCP audiences in select markets.
The information gathered from this evaluation will also be used to
inform refinement and implementation of the campaign (materials and
tactics).
CDC requests OMB approval for an estimated 842 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Consumer Audiences.................... BAA Consumer Pre- 473 1 20/60
Campaign Web Survey.
Consumer Audiences.................... BAA Consumer Post- 473 1 20/60
Campaign Web Survey.
HCP Audiences......................... BAA HCP................. 788 1 20/60
Consumer Audiences.................... BAA Consumer Pre- 473 1 20/60
Campaign Web Survey.
Pre-Campaign Web Survey. .............. .............. ..............
HCP Audiences......................... BAA HCP Post-Campaign 788 1 20/60
Web Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-22502 Filed 10-14-22; 8:45 am]
BILLING CODE 4163-18-P
